title: [Recommendations for the use of Sildenafil in patients with cardiac diseases].
authors.forename: C
authors.initials: C
authors.lastname: Akel
authors.forename: H
authors.initials: H
authors.lastname: Prat
authors.forename: C
authors.initials: C
authors.lastname: Carranza
authors.forename: H
authors.initials: H
authors.lastname: Chamorro
authors.forename: H
authors.initials: H
authors.lastname: Zárate
authors.forename: H
authors.initials: H
authors.lastname: López
authors.forename: M
authors.initials: M
authors.lastname: Hassi
authors.forename: A
authors.initials: A
authors.lastname: Forero
authors.forename: R
authors.initials: R
authors.lastname: Asenjo
authors.forename: M
authors.initials: M
authors.lastname: Pinto
authors.forename: P
authors.initials: P
authors.lastname: Marró
mesh_terms: D002318:Cardiovascular Diseases; D000075202:Contraindications; D017408:Guidelines as Topic; D006801:Humans; D008297:Male; D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D000068677:Sildenafil Citrate; D013450:Sulfones
chemical_list: D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D000068677:Sildenafil Citrate